Position in OCUL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,657,704
+$700,279 QoQ
Shares Held
270,642
+17.1% QoQ
Ownership
0.123%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 257 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 25%
Shared 0%
None 75%
Common Shares in OCUL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,298,250 across 329 Biotechnology names. OCUL ranks #83 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in OCUL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,657,704 | 270,642 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,957,425 | 231,101 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,929,636 | 241,321 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,571,893 | 220,008 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,093,085 | 225,548 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,635,432 | 223,115 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $1,824,152 | 213,601 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $1,808,895 | 207,919 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,445,298 | 211,301 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,382,799 | 151,956 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $508,283 | 113,965 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $408,250 | 130,016 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $630,670 | 122,223 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $568,290 | 107,835 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $284,773 | 101,343 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $412,227 | 99,332 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $363,789 | 90,495 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $438,901 | 88,667 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $607,212 | 87,118 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $889,620 | 88,962 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,206,959 | 85,117 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,370,661 | 83,526 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,774,300 | 85,715 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $538,331 | 70,740 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $636,370 | 76,395 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $283,407 | 57,254 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||